Safety and efficacy of different basal insulin in type 2 diabetes mellitus with chronic kidney disease in Ramadan / Nur Haziqah Baharum

Background: Diabetic kidney disease populations are categorized as high risk for fasting in Ramadan due to various potential fasting-related complications. Insulin analogue has been recommended in fasting during Ramadan, replacing human insulin due to the benefit oflower risk of hypoglycaemia and le...

Full description

Saved in:

Bibliographic Details
Main Author:	Baharum, Nur Haziqah
Format:	Thesis
Language:	English
Published:	2023
Subjects:	Diabetes Mellitus
Online Access:	https://ir.uitm.edu.my/id/eprint/95138/1/95138.PDF
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-uitm-ir.95138
record_format	uketd_dc
spelling	my-uitm-ir.951382024-08-21T02:15:01Z Safety and efficacy of different basal insulin in type 2 diabetes mellitus with chronic kidney disease in Ramadan / Nur Haziqah Baharum 2023 Baharum, Nur Haziqah Diabetes Mellitus Background: Diabetic kidney disease populations are categorized as high risk for fasting in Ramadan due to various potential fasting-related complications. Insulin analogue has been recommended in fasting during Ramadan, replacing human insulin due to the benefit oflower risk of hypoglycaemia and lesser glycaemic variability. There is paucity of data on the safety and efficacy of different types of basal insulin in diabetic kidney disease populations during fasting. This study aims to evaluate the safety and efficacy of three basal insulin among patients with type 2 diabetes mellitus and concomitant mild to moderate chronic kidney disease who are keen to fast during Ramadan. Materials and Methods: A single-centered, prospective observational study was conducted among 46 patients with type 2 diabetes mellitus and concomitant chronic kidney disease stage 2 and 3 who were on three different types of basal insulin (Glargine, Levemir, and lnsulatard), fasted in Ramadan 2022. All continuous variables were listed as median (IQR). Hypoglycaemia profile and glycemic variability obtained from Freestyle Libre continuous glucose monitoring were compared between insulin groups. Changes in glycated haemoglobin, fasting plasma glucose, renal profile, body weight, and waist circumference pre and post-Ramadan were evaluated. The predictors of high glycaemic variability were identified among insulin-treated patients in Ramadan. Results: The glycaemic variability was reported highest in lnsulatard with a median (IQR) of 37.2(33) % versus Levemir 34.4(32.4) % versus Glargine U-100 36.8(30.6) %, p= NS. Levemir had reported the lowest median time below range of 2.5 (13) % followed by Glargine 4(25) % and lnsulatard 5(8) %; p=NS. lnsulatard showed significant reduction in weight and waist circumference (0.9kg, p=0.026; 0.44 cm, p=0.008) while Levemir showed significant reduction in waist circumference (0.75cm p=0.019) post Ramadan. A higher number oflow glucose event is associated with 1.29 times fold increase probability of high glycemic variability and a higher percentage of time in range had probability of less glycaemic variability with OR of 0.90. Conclusion: lnsulatard, Levemir, and Glargine demonstrated similar safety and efficacy among those with diabetic kidney disease who fasted during Ramadan. Hypoglycaemia was identified as the clinical predictor for high glycaemic variability and time in range contribute to less glycaemic variability in Ramadan. Faculty of Medicine 2023 Thesis https://ir.uitm.edu.my/id/eprint/95138/ https://ir.uitm.edu.my/id/eprint/95138/1/95138.PDF text en public masters Universiti Teknologi MARA Faculty of Medicine
institution	Universiti Teknologi MARA
collection	UiTM Institutional Repository
language	English
topic	Diabetes Mellitus
spellingShingle	Diabetes Mellitus Baharum, Nur Haziqah Safety and efficacy of different basal insulin in type 2 diabetes mellitus with chronic kidney disease in Ramadan / Nur Haziqah Baharum
description	Background: Diabetic kidney disease populations are categorized as high risk for fasting in Ramadan due to various potential fasting-related complications. Insulin analogue has been recommended in fasting during Ramadan, replacing human insulin due to the benefit oflower risk of hypoglycaemia and lesser glycaemic variability. There is paucity of data on the safety and efficacy of different types of basal insulin in diabetic kidney disease populations during fasting. This study aims to evaluate the safety and efficacy of three basal insulin among patients with type 2 diabetes mellitus and concomitant mild to moderate chronic kidney disease who are keen to fast during Ramadan. Materials and Methods: A single-centered, prospective observational study was conducted among 46 patients with type 2 diabetes mellitus and concomitant chronic kidney disease stage 2 and 3 who were on three different types of basal insulin (Glargine, Levemir, and lnsulatard), fasted in Ramadan 2022. All continuous variables were listed as median (IQR). Hypoglycaemia profile and glycemic variability obtained from Freestyle Libre continuous glucose monitoring were compared between insulin groups. Changes in glycated haemoglobin, fasting plasma glucose, renal profile, body weight, and waist circumference pre and post-Ramadan were evaluated. The predictors of high glycaemic variability were identified among insulin-treated patients in Ramadan. Results: The glycaemic variability was reported highest in lnsulatard with a median (IQR) of 37.2(33) % versus Levemir 34.4(32.4) % versus Glargine U-100 36.8(30.6) %, p= NS. Levemir had reported the lowest median time below range of 2.5 (13) % followed by Glargine 4(25) % and lnsulatard 5(8) %; p=NS. lnsulatard showed significant reduction in weight and waist circumference (0.9kg, p=0.026; 0.44 cm, p=0.008) while Levemir showed significant reduction in waist circumference (0.75cm p=0.019) post Ramadan. A higher number oflow glucose event is associated with 1.29 times fold increase probability of high glycemic variability and a higher percentage of time in range had probability of less glycaemic variability with OR of 0.90. Conclusion: lnsulatard, Levemir, and Glargine demonstrated similar safety and efficacy among those with diabetic kidney disease who fasted during Ramadan. Hypoglycaemia was identified as the clinical predictor for high glycaemic variability and time in range contribute to less glycaemic variability in Ramadan.
format	Thesis
qualification_level	Master's degree
author	Baharum, Nur Haziqah
author_facet	Baharum, Nur Haziqah
author_sort	Baharum, Nur Haziqah
title	Safety and efficacy of different basal insulin in type 2 diabetes mellitus with chronic kidney disease in Ramadan / Nur Haziqah Baharum
title_short	Safety and efficacy of different basal insulin in type 2 diabetes mellitus with chronic kidney disease in Ramadan / Nur Haziqah Baharum
title_full	Safety and efficacy of different basal insulin in type 2 diabetes mellitus with chronic kidney disease in Ramadan / Nur Haziqah Baharum
title_fullStr	Safety and efficacy of different basal insulin in type 2 diabetes mellitus with chronic kidney disease in Ramadan / Nur Haziqah Baharum
title_full_unstemmed	Safety and efficacy of different basal insulin in type 2 diabetes mellitus with chronic kidney disease in Ramadan / Nur Haziqah Baharum
title_sort	safety and efficacy of different basal insulin in type 2 diabetes mellitus with chronic kidney disease in ramadan / nur haziqah baharum
granting_institution	Universiti Teknologi MARA
granting_department	Faculty of Medicine
publishDate	2023
url	https://ir.uitm.edu.my/id/eprint/95138/1/95138.PDF
_version_	1811768810553737216

Safety and efficacy of different basal insulin in type 2 diabetes mellitus with chronic kidney disease in Ramadan / Nur Haziqah Baharum

Similar Items